Britta Andersson

793 citations
6 papers · 707 · 1 hit paper · h-index 6

Impact in

    • Nanoparticle-Based Drug Delivery
    • Graphene and Nanomaterials Applications
    • Nanoplatforms for cancer theranostics
    • Bone Tissue Engineering Materials

Papers in

Britta Andersson

6 papers receiving 687 citations

Britta Andersson's Hit Papers

Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation 2010 · 458 citations
4580+5+10Years since publication100200300400

Peers

Britta Andersson
Comparison fields: 5 of 97
  • Biomaterials 233
  • Biomedical Engineering 303
  • Materials Chemistry 281
  • Drug Discovery 1
  • Electronic, Optical and Magnetic Materials 64
Replace Andrea Kunzmann with:
Andrea Kunzmann Sweden
Koki Kanehira Japan
Sing Ling Chia Singapore
Michael Motskin United Kingdom
Shuji Sonezaki Japan
Yinghua Qu China
Meena Mahmood United States
Yalin Cong China
Joël Bourquin Switzerland
Marianne E. Mertens Germany
Britta Andersson relative to Andrea Kunzmann Sweden Andrea Kunzmann's profile →
Citations per field
00.5×1.5×
Andrea Kunzmann · 1×
Citations per year

Countries citing papers authored by Britta Andersson

Since Specialization
Citations

This map shows the geographic impact of Britta Andersson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Britta Andersson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Britta Andersson more than expected).

Fields of papers citing papers by Britta Andersson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Britta Andersson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Britta Andersson. The network helps show where Britta Andersson may publish in the future.

Co-authors

The 21 scholars most cited alongside Britta Andersson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Britta Andersson Line = papers co-authored together Britta Andersson links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Toxicology of engineered nanomaterials: Focus on biocompatibility, biodistribution and biodegradation
Hit paper breakdown →
2010458
2 2011172
3 201132
4 200419
5 200815
6
Pharmacological modulation of lung cancer cells for potassium ion depletion.
200511

About Britta Andersson

Britta Andersson is a scholar working on Molecular Biology, Health, Toxicology and Mutagenesis, Biomaterials, Spectroscopy and Materials Chemistry, having authored 6 papers that have together received 707 indexed citations. Recurring topics across this work include Chemical Analysis and Environmental Impact (1 paper), Nanoparticles: synthesis and applications (1 paper), Lipid Membrane Structure and Behavior (1 paper), Nanoparticle-Based Drug Delivery (1 paper), Ion channel regulation and function (1 paper) and Molecular Sensors and Ion Detection (1 paper). The work is most often cited by research in Biomaterials (233 citations), Biomedical Engineering (303 citations), Materials Chemistry (281 citations), Drug Discovery (1 citation) and Electronic, Optical and Magnetic Materials (64 citations). Britta Andersson has collaborated with scholars based in Sweden, Switzerland and Belgium. Frequent co-authors include Andrea Kunzmann, Harald F. Krug, Tina Buerki‐Thurnherr, Bengt Fadeel, Annika Scheynius, Neus Feliu, Mamoun Muhammed, Fei Ye, Sophie Laurent and Muhammet S. Toprak. Their work appears in journals such as Basic & Clinical Pharmacology & Toxicology, Biochimica et Biophysica Acta (BBA) - General Subjects, Clinical Oral Implants Research, Cellular Physiology and Biochemistry and Toxicology and Applied Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact